SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-12-153768
Filing Date
2012-04-06
Accepted
2012-04-06 17:18:01
Documents
4
Period of Report
2012-05-11

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d330905dpre14a.htm PRE 14A 745233
2 GRAPHIC g330905g58m81.jpg GRAPHIC 35345
3 GRAPHIC g330905g66f71.jpg GRAPHIC 56165
4 GRAPHIC g330905g92o25.jpg GRAPHIC 5358
  Complete submission text file 0001193125-12-153768.txt   880168
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-24274 | Film No.: 12748572
SIC: 2836 Biological Products, (No Diagnostic Substances)